Biofire Diagnostics, LLC: FDA filings under this applicant name

FDA lists 26 510(k) clearances under the applicant name “Biofire Diagnostics, LLC” (first 2015, latest 2026), plus 4 De Novo decisions, across 11 product codes in 2 review panels. Median 510(k) review time under this name: 87 days. Since 2017 the median was 90 days, against 106 days for all cleared 510(k)s in the same product codes. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.

Caduvo groups this applicant name under bioMérieux, based on public ownership records.

510(k) clearances per year

YearClearancesMedian review days
20154100
2016527
2017190
20183181
20190—
2020190
2021126
2022159
2023229
2024460
20252150
20262126

Review time against the same product codes

Since 2017, 510(k)s cleared under the name Biofire Diagnostics, LLC took a median 90 days from FDA receipt to decision. All cleared 510(k)s in the same product codes over the same years took a median 106 days.

Top product codes

Product codeDeviceSubmissions510(k) clearances
PCHGastrointestinal Pathogen Panel Multiplex Nucleic Acid-Based Assay System66
PENGram-Negative Bacteria And Associated Resistance Markers55
QOFMulti-Target Respiratory Specimen Nucleic Acid Test Including Sars-Cov-2 And Other Microbial Agents54
OCCRespiratory Virus Panel Nucleic Acid Assay System44
PLOMeningitis/Encephalitis Pathogen Multiplex Nucleic Acid Detection System21
QDPRespiratory Panel22
QDSMers-Cov And Common Respiratory Pathogens Semi-Quantitative And Quantitative Multiplex Nucleic Acid Detection System22
NSUInstrumentation For Clinical Multiplex Test Systems11
PQAVaginitis And Bacterial Vaginosis Nucleic Acid Detection System11
PZFMers-Cov And Common Respiratory Pathogens Multiplex Nucleic Acid Detection System10

Plus 1 more product codes.

Review panels

Most recent Biofire Diagnostics, LLC 510(k) clearances

510(k)DeviceProduct codeDecision dateReview days
K262172BIOFIRE FILMARRAY Gastrointestinal 1.1 (GI1.1) Panel; BIOFIRE FILMARRAY Gastrointestinal 1.1 (GI1.1) Panel MidPCH2026-11-06133
K262136BIOFIRE SPOTFIRE Vaginitis (VG) PanelPQA2026-10-21118
K243544BIOFIRE SPOTFIRE Respiratory/Sore Throat Panel MiniQOF2025-08-14272
K243885BIOFIRE FILMARRAY Gastrointestinal (GI) Panel MidPCH2025-01-1629
K243759BIOFIRE Blood Culture Identification 2 (BCID2) Panel (RFIT-ASY-0147 (30 pack) RFIT-ASY-0148 (6 pack))PEN2024-12-2014
K242367BIOFIRE FILMARRAY Gastrointestinal (GI) PanelPCH2024-11-0790
K241194BIOFIRE SPOTFIRE Respiratory/Sore Throat (R/ST) Panel MiniQOF2024-05-3030
K232954BIOFIRE SPOTFIRE Respiratory/Sore Throat (R/ST) PanelQOF2024-03-26187
K230719BIOFIRE® SPOTFIRE® Respiratory (R) Panel MiniQOF2023-04-1329
K230404BIOFIRE FILMARRAY Gastrointestinal (GI) PanelPCH2023-03-1629

16 earlier clearances. See the full list in Caduvo.

PMA and De Novo decisions

NumberPathwayDeviceDecision date
DEN200066De NovoOrthopedic Infection Microbial Multiplex Nucleic Acid Detection System2022-04-29
DEN200031De NovoMulti-Target Respiratory Specimen Nucleic Acid Test Including Sars-Cov-2 And Other Microbial Agents2021-03-17
DEN170017De NovoMers-Cov And Common Respiratory Pathogens Multiplex Nucleic Acid Detection System2017-11-24
DEN150013De NovoMeningitis/Encephalitis Pathogen Multiplex Nucleic Acid Detection System2015-10-08

Recalls

46 product recalls in 34 recall events; 30 initiated in the last five years. Most recent: 2026-08-12.

Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.

Device clinical trials

An industry sponsor named Biofire Diagnostics, LLC is the lead sponsor of 2 device studies on ClinicalTrials.gov (0 active or recruiting). Most recent:

Other FDA applicant names starting with the same word

FDA records these as separate applicants. Some may belong to the same corporate group and some may not; their filings are not included in the counts above.

Frequently asked questions

How many FDA 510(k) clearances are listed under Biofire Diagnostics, LLC?

FDA lists 26 510(k) clearances under the applicant name “Biofire Diagnostics, LLC” (first 2015, latest 2026), plus 4 De Novo decisions, across 11 product codes in 2 review panels. Filings under other applicant names, such as subsidiaries, are not included.

How long has FDA taken to clear 510(k)s filed by Biofire Diagnostics, LLC?

The median time from FDA receipt to decision across 510(k)s cleared under the name Biofire Diagnostics, LLC is 87 days. Since 2017: 90 days, versus 106 days for all cleared 510(k)s in the same product codes.

Which FDA product codes appear under Biofire Diagnostics, LLC?

The most frequent FDA product codes under this applicant name are PCH (Gastrointestinal Pathogen Panel Multiplex Nucleic Acid-Based Assay System, 6); PEN (Gram-Negative Bacteria And Associated Resistance Markers, 5); QOF (Multi-Target Respiratory Specimen Nucleic Acid Test Including Sars-Cov-2 And Other Microbial Agents, 5).

Next steps

Compiled by Caduvo from public U.S. government records. Counts cover filings under the applicant name shown on this page only. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA or any other agency, or by the companies named. Not regulatory advice. Report an error in this data. Data and corrections policy.

All FDA device companies · FDA product code lookup